GRI Genes Research Roundtable Summary 

CureGRIN Foundation hosted our seventh GRI Genes Roundtable on July 8. Our goal is to promote collaboration so that we can accelerate the path to treatments and cures for GRI Disorders.

We brought together researchers and clinicians studying GRI Disorders, GRIN genes, GRIA genes, GRIK genes, NMDA receptors, and other ionotropic receptors (AMPARs, kainate receptors, and delta receptors) to discuss and exchange ideas on GRIN, GRIA, and GRIK variants. There were 50 participants present for the meeting.

Keith McArthur (CureGRIN, CEO/Head of Science) unveiled the new name of the meeting, the GRI Genes Roundtable. We asked Heather Cartwright to share her family story about her son with a variant in GRIA4. Additionally, a panel of seven researchers presented on their work on GRIN, GRIA, and GRIK gene variants. Following the presentations, we also had time for a few questions for the panelists. This document summarizes these presentations.

This document summarizes these presentations and the group discussion.

This discussion happened before the Research Roadmap was finalized. You can view the final product here.

Our next GRI Genes Research Roundtable is scheduled for: Thursday, September 9, 2021.

If you are a GRIN / NMDAR researcher and/or a GRIA genes/AMPAR researcher or clinician, please reach out to meagan@curegrin.org to be added to the next meeting invitation.